United States of America #9019 (v.2)
Base data
- Notified in
-
G/MA/QR/N/USA/7 22/10/2024
- Version validity
-
01/10/2024 -
present
Current active version v.2
- Reporting member
- United States of America
- In force from
- End date
- In force
- General description
-
Prohibition on introduction into commerce of viruses, therapeutic serum, toxin, antitoxin, or analogous product, or arsphenamine or its derivatives (or any other trivalent organic arsenic compound), applicable to the prevention, treatment, or cure of diseases or injuries of man, unless subject to license
- National legal basis
-
Public Health Service Act, § 351(a)&(i)(42 U.S.C. § 262(a)&(i))
- Administrative mechanism
-
Department of Health and Human Services
- Responsible entities
-
Department of Health and Human Services
- HS version
-
HS 2022
- Referenced WTO document symbol
Meta data
- WTO justifications
-
No specific provision provided
No specific provision provided
Reported as: Protection of human, animal or plant life or health, inter alia - Non-WTO commitments
-
- Affected partners
- Non-affected partners
Measures
- Reported restrictions
- CP
| Symbol |
|---|
|
CP
|
Tariff lines
|
30
|
Various codes within HS Chapter 30
|
Viruses, therapeutic serum, toxin, antitoxin, or analogous product, or arsphenamine or its derivativ...
|
|